{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:02:56Z","timestamp":1789614176572,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10157-026-02900-2","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:07:24Z","timestamp":1781842044000},"page":"1468-1474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of frailty on prognosis in elderly patients with organ-threatening ANCA-associated vasculitis"],"prefix":"10.1007","volume":"30","author":[{"given":"Kenta","family":"Taito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoruko","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Yatabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0675-5075","authenticated-orcid":false,"given":"Mitsuyo","family":"Itabashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"2900_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet. 2013;381:752\u201362.","journal-title":"Lancet"},{"key":"2900_CR2","first-page":"1","volume":"69","author":"JS Andrews","year":"2017","unstructured":"Andrews JS, Trupin L, Yelin EH, et al. Frailty and reduced physical function in rheumatoid arthritis. Arthritis Care Res. 2017;69:1\u20138.","journal-title":"Arthritis Care Res"},{"key":"2900_CR3","first-page":"1","volume":"37","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Miloslavsky EM. Management of ANCA-associated vasculitis in older adults. Drugs Aging. 2020;37:1\u201313.","journal-title":"Drugs Aging"},{"key":"2900_CR4","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham Vasculitis Activity Score (BVAS). Ann Rheum Dis. 2009;68:1827\u201332.","journal-title":"Ann Rheum Dis"},{"key":"2900_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, Song X, MacKnight C. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489\u201395.","journal-title":"CMAJ"},{"key":"2900_CR6","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1093\/rheumatology\/kex291","volume":"57","author":"JC Robson","year":"2018","unstructured":"Robson JC, Dawson J, Cronholm PF, et al. Health-related quality of life in ANCA-associated vasculitis. Rheumatology. 2018;57:ii14\u201322.","journal-title":"Rheumatology"},{"key":"2900_CR7","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/acr.20649","volume":"64","author":"G Tomasson","year":"2012","unstructured":"Tomasson G, Boers M, Walsh M, et al. Damage and QOL in AAV. Arthritis Care Res. 2012;64:1050\u20136.","journal-title":"Arthritis Care Res"},{"key":"2900_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/rheumatology\/kez388","volume":"59","author":"D McGovern","year":"2020","unstructured":"McGovern D, Williams SP, Parsons K, et al. Frailty predicts mortality in ANCA-associated vasculitis. Rheumatology. 2020;59:1\u20138.","journal-title":"Rheumatology"},{"key":"2900_CR9","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1016\/S2665-9913(24)00193-0","volume":"6","author":"R Smith","year":"2024","unstructured":"Smith R, Jones A, Patel M, et al. Frailty as a predictor of outcomes in ANCA-associated vasculitis: a multicentre cohort study. Lancet Rheumatology. 2024;6:e771\u20139.","journal-title":"Lancet Rheumatology"},{"key":"2900_CR10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/ageing\/afx081","volume":"46","author":"RE Hubbard","year":"2017","unstructured":"Hubbard RE, Peel NM, Samanta M, et al. Frailty and hospitalization outcomes. Age Ageing. 2017;46:451\u20136.","journal-title":"Age Ageing"},{"key":"2900_CR11","doi-asserted-by":"crossref","unstructured":"Floyd L, Byrne L, Morris AD, Nixon AC, Dhaygude A. The limitations of frailty assessment tools in AAV, J Frailty aging 12: 139\u2013142.","DOI":"10.14283\/jfa.2023.14"},{"key":"2900_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"key":"2900_CR13","first-page":"1","volume":"45","author":"RJ Black","year":"2015","unstructured":"Black RJ, Hill CL, Lester S, et al. Infection risk in vasculitis. Semin Arthritis Rheum. 2015;45:1\u20136.","journal-title":"Semin Arthritis Rheum"},{"key":"2900_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for AAV. N Engl J Med. 2010;363:221\u201332.","journal-title":"N Engl J Med"},{"key":"2900_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne DRW, Merkel PA, Schall TJ, Bekker P. Avacopan for the treatment of AAV. N Engl J Med. 2021;384:599\u2013609.","journal-title":"N Engl J Med"},{"key":"2900_CR16","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates M, Watts RA, Bajema IM, et al. EULAR recommendations for AAV management. Ann Rheum Dis. 2016;75:1583\u201394.","journal-title":"Ann Rheum Dis"},{"key":"2900_CR17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2020.104040","volume":"49","author":"C Pagnoux","year":"2020","unstructured":"Pagnoux C. Updates in AAV management. Presse Med. 2020;49:104039.","journal-title":"Presse Med"},{"key":"2900_CR18","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/bmj.317.7172.1572","volume":"317","author":"DG Altman","year":"1998","unstructured":"Altman DG, Bland JM. Statistics notes: survival probabilities. BMJ. 1998;317:1572\u201380.","journal-title":"BMJ"},{"key":"2900_CR19","first-page":"1559","volume":"62","author":"N Basu","year":"2010","unstructured":"Basu N, Jones GT, Fluck N, et al. Fatigue and quality of life in AAV. Arthritis Care Res. 2010;62:1559\u201365.","journal-title":"Arthritis Care Res"},{"key":"2900_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/gerona\/59.3.M255","volume":"59","author":"LP Fried","year":"2004","unstructured":"Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity. J Gerontol A Biol Sci Med Sci. 2004;59:255\u201363.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2900_CR21","first-page":"3311","volume":"63","author":"WG Dixon","year":"2011","unstructured":"Dixon WG, Suissa S, Hudson M. The association between systemic glucocorticoids and infection. Arthritis Rheum. 2011;63:3311\u201320.","journal-title":"Arthritis Rheum"},{"key":"2900_CR22","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1359\/jbmr.2002.17.3.465","volume":"17","author":"TP van Staa","year":"2002","unstructured":"van Staa TP, Leufkens HG, Cooper C. Glucocorticoids and fracture risk. J Bone Miner Res. 2002;17:981\u20138.","journal-title":"J Bone Miner Res"},{"key":"2900_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrrheum.2016.220","volume":"13","author":"C Strehl","year":"2017","unstructured":"Strehl C, Bijlsma JW, de Wit M, et al. Glucocorticoid-induced adverse effects in rheumatic diseases. Nat Rev Rheumatol. 2017;13:133\u201343.","journal-title":"Nat Rev Rheumatol"},{"key":"2900_CR24","volume":"19","author":"A Kronbichler","year":"2020","unstructured":"Kronbichler A, Leierer J, Shin JI, et al. Infection in AAV: a major cause of mortality. Autoimmun Rev. 2020;19:102532.","journal-title":"Autoimmun Rev"},{"key":"2900_CR25","first-page":"509","volume":"16","author":"S Furuta","year":"2020","unstructured":"Furuta S, Jayne D. Emerging therapies in AAV. Nat Rev Rheumatol. 2020;16:509\u201324.","journal-title":"Nat Rev Rheumatol"},{"key":"2900_CR26","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jamda.2019.08.009","volume":"20","author":"E Dent","year":"2019","unstructured":"Dent E, Morley JE, Cruz-Jentoft AJ, et al. Physical frailty: pathways and interventions. J Am Med Dir Assoc. 2019;20:1190\u20132.","journal-title":"J Am Med Dir Assoc"},{"key":"2900_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clnu.2018.05.024","volume":"38","author":"D Volkert","year":"2019","unstructured":"Volkert D, Beck AM, Cederholm T, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr. 2019;38:10\u201347.","journal-title":"Clin Nutr"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02900-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02900-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02900-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:51:23Z","timestamp":1789613483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02900-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2900"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02900-2","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflict of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}